Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019

Saudi Med J. 2020 Aug;41(8):779-790. doi: 10.15537/smj.2020.8.25222.

Abstract

[No Abstract Available] Saudi Med J 2020; Vol. 41 (8): 779-790doi: 10.15537/smj.2020.8.25222 How to cite this article:Yaser A. Faden, Nadia A. Alghilan, Samiha H. Alawami, Eman S. Alsulmi, Hythem A. Alsum, Yasir A. Katib, Yasser S. Sabr, Fadwah H. Tahir, Nabeel S. Bondagji. Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019. Saudi Med J 2020; Vol. 41 (8): 779-790. doi: 10.15537/smj.2020.8.25222.

Publication types

  • Practice Guideline

MeSH terms

  • Anticoagulants / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Congenital Abnormalities / virology
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / transmission
  • Critical Illness
  • Delivery, Obstetric / methods
  • Female
  • Heparin / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Magnesium Sulfate / therapeutic use
  • Pandemics
  • Perinatology
  • Personal Protective Equipment
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / transmission
  • Postnatal Care
  • Pregnancy
  • Pregnancy Complications, Infectious / therapy*
  • Pregnancy Outcome
  • Prenatal Care / methods*
  • SARS-CoV-2
  • Saudi Arabia
  • Societies, Medical
  • Thromboembolism / prevention & control
  • Tocolytic Agents / therapeutic use

Substances

  • Anticoagulants
  • Antiviral Agents
  • Tocolytic Agents
  • Hydroxychloroquine
  • Magnesium Sulfate
  • Heparin